# NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events

Study · id `cardio:ct-nct04205578` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04205578](<https://clinicaltrials.gov/study/NCT04205578>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04205578

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.

## Technical summary

Registry record NCT04205578. Randomized; single masking; primary purpose diagnostic. Start 2020-01 (anticipated); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT04205578, source copy `cardio:ctgov-nct04205578-2019-12-19`, retrieved 2026-10-26)
- Planned start: 2020-01 (anticipated) (ClinicalTrials.gov record NCT04205578, source copy `cardio:ctgov-nct04205578-2019-12-19`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT04205578, source copy `cardio:ctgov-nct04205578-2019-12-19`, retrieved 2026-10-26)
- Completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT04205578, source copy `cardio:ctgov-nct04205578-2019-12-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04205578, source copy `cardio:ctgov-nct04205578-2019-12-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04205578-2019-12-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
- Acronym: NICE-MMD
- Condition: Moyamoya Disease
- Condition: Ischemic Cerebral Infarction
- Condition: Ischemic Stroke
- Condition: Ischemic Cerebrovascular Accident
- Condition: Transient Ischemic Attack
- Intervention (Drug): dl-3-n-butylphthalide (NBP)
- Intervention (Drug): Normal Saline 0.9% Infusion Solution
- Lead sponsor: yuanli Zhao
- Lead sponsor class: OTHER
- Collaborator: Peking University International Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Moyamoya disease (`cardio:moyamoya-disease`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 7fb0c2800ad3be7e309b1fed9d77871530ec6c33401bcc138e1be5284bf24dee
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
